Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Feb;39(2):144-50.
doi: 10.1007/s001170050489.

[PTA vs. stent in femoro-popliteal obstruction]

[Article in German]
Affiliations
Clinical Trial

[PTA vs. stent in femoro-popliteal obstruction]

[Article in German]
M Cejna et al. Radiologe. 1999 Feb.

Abstract

Purpose: To evaluate whether primary stenting is superior to balloon angioplasty (PTA) alone in the treatment of femoropopliteal obstructive disease.

Materials and methods: Sixty-two patients, 24 female and 38 male, mean age 67 years (39-87) years, were randomized to PTA alone (n = 37) or balloon angioplasty followed by implantation of Palmaz stents (n = 33). Follow-up included clinical assessment, ankle-brachial index (ABI), color duplex ultrasound at 1, 3, 6 and 12 months after intervention and intravenous angiography at 6 or 12 months.

Results: We had four cases of primary PTA failures (10.8%) and no early (< 30 days) thrombosis compared to one primary stent failure (3.0%) and three early thromboses (9.0%) in the stent group. Cumulative primary angiographic patency rates (life-table analysis) for PTA alone were 82% and 72% (6 and 12 months, respectively) compared to 81% and 60% for primary stent placement. The secondary angiographic patency were 97% and 88% for PTA and 88% and 72% for stent implantation, respectively. However, there was no significant difference in patency rates.

Conclusions: Despite fewer primary technical failures, mid-term angiographic and clinical patency were not improved by primary stent placement compared to PTA alone.

PubMed Disclaimer

LinkOut - more resources